Company Directory / research

PrivateFor profitresearchSan Diego, United States
Primmune Therapeutics is a Biotechnology company.
Size
1-10 people: larger than 0% of companies with a size listed
Age
9 years old.
Reach
No web traffic ranking listed.
BiotechnologyHealth Care
Funding, as listed
$48M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Primmune Therapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Primmune Therapeutics may be growing as the company has reached a stage where it is presenting clinical data from a Phase 1 study, which indicates progress in its product development pipeline. The presentation of data from the study evaluating PRTX007 in healthy volunteers suggests that the company is advancing its research and development efforts. This progression into clinical trials is a critical step for biotechnology companies and often correlates with increased investment and interest in the company's potential.
Summaries written by the source dataset, not by us, and not checked.
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.